KURA ONCOLOGY INC. - COMMON STOCK
7.3200
10-يناير-25 15:45:00
15 متأخرة بدقائق
الأسهم
-0.4600
-5.91%
نطاق اليوم
7.1750 - 7.7286
ISIN
N/A
المصدر
NASDAQ
-
23 أكتوبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
30 سبتمبر 2024 17:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
17 سبتمبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Cantor Global Healthcare Conference
10 سبتمبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Second Quarter 2024 Financial Results
08 أغسطس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
08 أغسطس 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Report Second Quarter 2024 Financial Results
01 أغسطس 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
24 يونيو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 يونيو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Jefferies Global Healthcare Conference
29 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
14 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
08 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports First Quarter 2024 Financial Results
02 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Report First Quarter 2024 Financial Results
25 أبريل 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
22 أبريل 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Stifel Targeted Oncology Forum
10 أبريل 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 أبريل 2024 06:30:00 بحسب Nasdaq GlobeNewswire
-
NetDania - New 12 months High: KURA ONCOLOGY INC. - COMMON STOCK
11 مارس 2024 08:53:56 بحسب NetDania Notify